News
The $240 bln pharma giant is pausing a $271 mln research project amid an investment row with Britain’s government. Big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback